Visual deficit possibly caused by lutetium-177 PSMA treatment
نویسندگان
چکیده
منابع مشابه
Is dyslexia caused by a visual deficit?
A number of studies have found that dyslexic readers suffer from visual deficits A causal relationship has yet to be established. One step toward establishing such a relationship would be to demonstrate that the degree of dyslexia can be altered by manipulating a purely visual variable. One such variable would be the size of the printed text. In a recent study (O'Brien, Mansfield, & Legge, 2000...
متن کاملLutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System
OBJECTIVES Peptide Receptor Radionuclide Therapy (PRRT) with yttrium-90 ((90)Y) and lutetium-177 ((177)Lu)-labelled SST analogues are now therapy option for patients who have failed to respond to conventional medical therapy. In-house production with automated PRRT synthesis systems have clear advantages over manual methods resulting in increasing use in hospital-based radiopharmacies. We repor...
متن کاملLutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System
Objective(s): Peptide Receptor Radionuclide Therapy (PRRT) with yttrium-90 (90Y) and lutetium-177 (177Lu)-labelled SST analogues are now therapy option for patients who have failed to respond to conventional medical therapy. In-house production with automated PRRT synthesis systems have clear advantages over manual methods resulting in increasing use in hospital-based radiopharmacies. We report...
متن کاملRhombencephalitis possibly caused by Mycoplasma pneumoniae.
Santa Casa de Belo Horizonte, Belo Horizonte MG, Brazil: MD, PhD, Department of Neurology.; MD, Department of Neurology. Mycoplasma pneumoniae is a frequent cause of respiratory infection in humans, especially schoolchildren, adolescents and young adults, accounting for about 20% of cases of pneumonia in this age group. However, little is known about its extrapulmonary manifestations, with the ...
متن کاملLutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy
Prostate-specific membrane antigen (PSMA) is a receptor on the surface of prostate cancer cells that is revolutionising the way we image and treat men with prostate cancer. New small molecule peptides with high-binding affinity for the PSMA receptor have allowed high quality, highly specific PET imaging, in addition to the development of targeted radionuclide therapy for men with prostate cance...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ Case Reports
سال: 2018
ISSN: 1757-790X
DOI: 10.1136/bcr-2018-225508